Key Takeaways EMN posted Q2 adjusted EPS of $1.60, down from$2.15 last year and below the consensus estimate.Eastman Chemical's Q2 sales fell 3% year over year to $2.29B, missing estimates amid weak end-market demand.EMN expects Q3 adjusted EPS of$1.25 and full-year operating cash flow of approximately $1 billion.Eastman Chemical Company (EMN) logged second-quarter 2025 earnings of$1.20 per share, a roughly 38% decline from the year-ago quarter's figure of $1.94.EMN posted adjusted earnings of$1.60 per ...